Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs Niagen Bioscience
Over the past year BBOT returned −80.8% and NAGE returned −66.9%; their daily moves had a correlation of 0.14.
BBOT −80.8% NAGE −66.9%Growth of $1, one year, split-adjusted
| Metric | BBOT | NAGE |
|---|---|---|
| Price | $2.36 | $2.39 |
| Market cap | $189.2M | $189.1M |
| Today | −9.92% | +2.58% |
| 1 month | −39.3% | −14.3% |
| 6 months | −72.1% | −51.5% |
| Year to date | −81.2% | −62.4% |
| 1 year | −80.3% | −66.4% |
| Revenue growth (YoY) | — | −4.3% |
| Gross margin | — | 64.8% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 11.8× |
| Price / sales | — | 1.5× |
| Net cash | $225.7M | $66.7M |
| Dividend yield | — | — |
| Volatility (60d) | 86.9% | 37.1% |
| Short % of float | 13.9% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).